Cardiovascular. All GLP-1RAs increase heart rate, and this is not different for semaglutide. In SUSTAIN 6, a placebo-corrected heart rate increase of 2.75 beats per minute (bpm) was observed for semaglutide 0.5 mg, and 3.2 bpm for the 1.0 mg dosage (97). This increase was not associated with adverse cardiac events.

1. Semaglutide, a glucagon like peptide-1 receptor agonist with - NCBI

  • Author: nih.gov
  • Updated: 2022-09-24
  • Rated: 76/100 ⭐ (4169 votes)
  • High rate: 79/100 ⭐
  • Low rate: 55/100 ⭐
  • Summary: Semaglutide, a glucagon like peptide
  • Matched Content: A 10-week long, placebo-controlled trial investigated the safety, tolerability, pharmacokinetics and dynamic effects of oral semaglutide on 107 
  • Read more: here
  • Edited by: Bennie Dorthea

2. Efficacy and safety of semaglutide in glycemic control, body weight

  • Author: springer.com
  • Updated: 2022-09-24
  • Rated: 96/100 ⭐ (4376 votes)
  • High rate: 97/100 ⭐
  • Low rate: 56/100 ⭐
  • Summary: Efficacy and safety of semaglutide in glycemic control, body weight
  • Matched Content: Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 
  • Read more: here
  • Edited by: Tallia Hueston

3. Pharmacological profile of once-weekly injectable semaglutide for

  • Author: tandfonline.com
  • Updated: 2022-09-24
  • Rated: 89/100 ⭐ (1264 votes)
  • High rate: 89/100 ⭐
  • Low rate: 64/100 ⭐
  • Summary: Pharmacological profile of once
  • Matched Content: Efficacy and safety of semaglutide compared with liraglutide for weight loss in people with obesity in a phase. 2 dose-finding study.
  • Read more: here
  • Edited by: Oralla Christabelle

4. Effects of Semaglutide on Glycemic Control and Weight Loss in a

  • Author: benthamscience.com
  • Updated: 2022-09-23
  • Rated: 97/100 ⭐ (4918 votes)
  • High rate: 97/100 ⭐
  • Low rate: 54/100 ⭐
  • Summary: Effects of Semaglutide on Glycemic Control and Weight Loss in a
  • Matched Content: Further studies are required to confirm the efficacy and safety of semaglutide in patients with Prader-Willi syndrome. Keywords: Semaglutide 
  • Read more: here
  • Edited by: Alica Dermot

5. Efficacy and safety of semaglutide compared with liraglutide and

  • Author: researchgate.net
  • Updated: 2022-09-23
  • Rated: 96/100 ⭐ (1965 votes)
  • High rate: 97/100 ⭐
  • Low rate: 54/100 ⭐
  • Summary: Efficacy and safety of semaglutide compared with liraglutide and
  • Matched Content: Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of 
  • Read more: here
  • Edited by: Alida Deroo

6. Real-world use of once-weekly semaglutide in patients with type 2

  • Author: frontiersin.org
  • Updated: 2022-09-23
  • Rated: 79/100 ⭐ (3456 votes)
  • High rate: 79/100 ⭐
  • Low rate: 45/100 ⭐
  • Summary: weekly semaglutide in patients with type 2
  • Matched Content: The reported adverse events were consistent with the known safety profile of semaglutide. Conclusions: In routine clinical practice in Spain 
  • Read more: here
  • Edited by: Lian Girardi

7. Abstract - Amsterdam UMC research portal

  • Author: amsterdamumc.org
  • Updated: 2022-09-23
  • Rated: 66/100 ⭐ (1274 votes)
  • High rate: 79/100 ⭐
  • Low rate: 66/100 ⭐
  • Summary: Amsterdam UMC research portal
  • Matched Content: Corrigendum: Safety of Semaglutide (Front. Endocrinol., (2021), 12, (645563), Journal, Frontiers in Endocrinology. Volume, 12.
  • Read more: here
  • Edited by: Emalee Ewall

8. Safety of Semaglutide - PMC - NCBI

  • Author: nih.gov
  • Updated: 2022-09-23
  • Rated: 79/100 ⭐ (2494 votes)
  • High rate: 79/100 ⭐
  • Low rate: 44/100 ⭐
  • Summary: Safety of Semaglutide PMC
  • Matched Content: No unexpected safety issues have arisen to date, and the established safety profile for semaglutide is similar to that of other GLP-1RAs 
  • Read more: here
  • Edited by: Valina Dalpe

9. Efficacy and Safety of the New Appetite Suppressant, Liraglutide

  • Author: e-enm.org
  • Updated: 2022-09-23
  • Rated: 99/100 ⭐ (8917 votes)
  • High rate: 99/100 ⭐
  • Low rate: 44/100 ⭐
  • Summary: Efficacy and Safety of the New Appetite Suppressant, Liraglutide
  • Matched Content: Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, 
  • Read more: here
  • Edited by: Zahara Issi

10. New practice in semaglutide on type-2 diabetes and obesity - Springer

  • Author: springer.com
  • Updated: 2022-09-23
  • Rated: 96/100 ⭐ (1626 votes)
  • High rate: 98/100 ⭐
  • Low rate: 65/100 ⭐
  • Summary: New practice in semaglutide on type
  • Matched Content: Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, 
  • Read more: here
  • Edited by: Sapphira Hilliard

11. Ozempic (Semaglutide) for the treatment of obesity

  • Author: rsdjournal.org
  • Updated: 2022-09-23
  • Rated: 67/100 ⭐ (5275 votes)
  • High rate: 77/100 ⭐
  • Low rate: 45/100 ⭐
  • Summary: for the treatment of obesity
  • Matched Content: O'Neil P. M. et al (2018) Efficacy and safety of semaglutide compared Expert Opinion on Drug Safety. Frontiers in Endocrinology, 12.
  • Read more: here
  • Edited by: Joanna Bolanger

12. Safety of Semaglutide - ReadCube

  • Author: readcube.com
  • Updated: 2022-09-23
  • Rated: 78/100 ⭐ (7579 votes)
  • High rate: 78/100 ⭐
  • Low rate: 44/100 ⭐
  • Summary: Safety of Semaglutide ReadCube
  • Matched Content: Frontiers in Endocrinology | www.frontiersin.org July 2021 | Volume 12 | Article 645563 an adequate review of the safety of semaglutide.
  • Read more: here
  • Edited by: Vi Dane

13. Abstract

  • Author: vumc.nl
  • Updated: 2022-09-23
  • Rated: 87/100 ⭐ (2417 votes)
  • High rate: 87/100 ⭐
  • Low rate: 44/100 ⭐
  • Summary: Abstract 2022
  • Matched Content: Corrigendum: Safety of Semaglutide (Front. Endocrinol., (2021), 12, (645563), Journal, Frontiers in Endocrinology. Volume, 12.
  • Read more: here
  • Edited by: Latrena Brownson

14. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of

  • Author: diabetesjournals.org
  • Updated: 2022-09-23
  • Rated: 96/100 ⭐ (2344 votes)
  • High rate: 97/100 ⭐
  • Low rate: 46/100 ⭐
  • Summary: Randomized Clinical Trial of the Efficacy and Safety of
  • Matched Content: OBJECTIVE. This trial compared the efficacy and safety of the first oral glucagon-like peptide 1 (GLP-1) receptor agonist, oral semaglutide, 
  • Read more: here
  • Edited by: Eachelle Averill

15. Efficacy and Safety of Subcutaneous and Oral Semaglutide

  • Author: frontiersin.org
  • Updated: 2022-09-23
  • Rated: 68/100 ⭐ (4145 votes)
  • High rate: 88/100 ⭐
  • Low rate: 64/100 ⭐
  • Summary: Efficacy and Safety of Subcutaneous and Oral Semaglutide
  • Matched Content: Among the included studies on subcutaneous semaglutide administration, five trials investigated its efficacy and safety compared to placebo ( 
  • Read more: here
  • Edited by: Dulcea Ester